lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations
lnc-MPEG1-1 is a novel lncRNA linked to BRAF mutations, promoting PTC progression. It holds potential as a prognostic biomarker and therapeutic target, particularly in BRAF-mutant PTC cases.
Authors
- Wenjing Yang (ORCID: https://orcid.org/0000-0002-6997-0406)
- Hong Shen (ORCID: https://orcid.org/0000-0001-5345-4709)
- Qian Wang (ORCID: https://orcid.org/0000-0001-5246-3611)
- Li Zhao (ORCID: https://orcid.org/0000-0002-7703-5397)
- Bojun Wei (ORCID: https://orcid.org/0000-0002-3633-3232)
- Dalin Feng
- Teng Zhao
- Rongfang Shen
- Xing Liu (ORCID: https://orcid.org/0009-0009-2475-9736)
- Jiacheng Wang (ORCID: https://orcid.org/0000-0003-0738-4732)
Institutions
- Capital Medical University (CN)
- Beijing Chaoyang Emergency Medical Center (CN)
Publication Details
- Journal
- Endokrynologia Polska
- Published
- 2025-10-09
- DOI
- https://doi.org/10.5603/ep.105397
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00